Growth factor signalling

International Journal of Developmental Biology

Volumn 43, Issue 7, 1999, Pages 681-691

  De Laat, Siegfried W ^a   Boonstra, Johannes ^b   Defize, Libert H K ^a   Kruijer, Wiebe ^b   Van Der Saag, Paul T ^a   Tertoolen, Leon G J ^a   Van Zoelen, Everardus J J ^b   Den Hertog, Jeroen ^a  

^a HUBRECHT INSTITUTE   (Netherlands)

^b NONE

Author keywords

Development; Growth factor (receptor); Proliferation; Second messengers; Signalling

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR;

ANIMAL CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CELL LINE; EMBRYO; GROWTH SUBSTANCES; INOSITOL PHOSPHATES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, GROWTH FACTOR; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTORS;

ANIMALIA; VERTEBRATA;

EID: 0033394721     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. ANGEL, P., HATTORI, K., SMEAL, T. and KARIN, M. (1988).The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55: 875-885.
2. ANZANO, M.A., ROBERTS, A.B., MEYERS, C.A., KOMORIYA, A., LAMB, L.C., SMITH, J.M. and SPORN, M.B. (1982). Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res. 42: 4776-4778.
3. ARONHEIM, A., ENGELBERG, D., LI, N., AL-ALAWI, N., SCHLESSINGER, J. and KARIN, M. (1994). Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78: 949-961.
4. BELLOT, F., MOOLENAAR, W.H., KRIS, R., MIRAKHUR, B., VERLAAN, I., ULLRICH, A., SCHLESSINGER, J. and FELDER, S. (1990). High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses. J. Cell Biol. 110: 491-502.
5. BERRIDGE, M.J. and IRVINE, R.F. (1989). Inositol phosphates and cell signalling. Nature 341: 197-205.
6. BERTICS, P.J. and GILL, G.N. (1985). Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor. J. Biol. Chem. 260: 14642-14647.
7. BONI-SCHETZLER, M. and PILCH, P.F. (1987). Mechanism of epidermal growth factor receptor autophosphorylation and high affinity binding. Proc. Natl. Acad. Sci. USA. 84: 7832-7836.
8. BOONSTRA, J., VAN BELZEN, N., VAN MAURIK, P., HAGE, W.J., BLOK, F.J., WIEGANT, F.A.C. and VERKLEIJ, A.J. (1985). Immunocytochemical demonstrations of cytoplasmic and cell-surface EGF-receptors in A431 cells using cryoultramicrotomy, surface replication, freeze etching and label fracture. J. Microsc. (Oxford) 140: 119-129.
9. BOS, J.L. (1998). All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. EMBO J. 17: 6776-6782.
10. BUDAY, L. and DOWNWARD, J. (1993). Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73: 611-620.
11. CHENG, A.M., SAXTON, T.M., SAKAI, R., KULKARNI, S., MBAMALU, G., VOGEL, W., TORTORICE, C.G., CARDIFF, R.D., CROSS, J.C., MULLER, W.J. and PAWSON, T. (1998). Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 95: 793-803.
12. CLARK, S.G., STERN, M.J. and HORVITZ, H.J. (1992). C. elegans cell signalling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature 356: 340-344.
13. COCHET, C., KASHLES, O., CHAMBAZ, E.M., BORELLO, I., KING, C.R. and SCHLESSINGER, J. (1988). Demonstration of EGF-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. J. Biol. Chem. 263: 3290-3295.
14. COHEN, S. (1962). Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new born animal. J. Biol. Chem. 237: 1555-1562.
15. DAS, M., MIYAKAWA, T., FOX, C.F., PRUSS, R.M., AHARONOV, A. and HERSCHMAN, H.R. (1977). Specific radiolabeling of a cell surface receptor for epidermal growth factor. Proc. Natl. Acad. Sci. USA 74: 2790-2794.
16. DE GROOT, R.P., KRUYT, F.A., VAN DER SAAG, P.T. and KRUIJER, W. (1990a). Ectopic expression of c-jun leads to differentiation of P19 embryonal carcinoma cells. EMBO J. 9: 1831-1837.
17. DE GROOT, R.P., SCHOORLEMMER, J., VAN GENESEN, ST. and KRUIJER, W. (1990b). Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells. Nucleic Acids Res. 18: 3195-3202.
18. DE LAAT, S.W. and VAN DER SAAG, P.T. (1982). The plasma membrane as a regulatory site in growth and differentiation of neuroblastoma cells. Int. Rev. Cytol. 74: 1-54.
19. DE LARCO, J.E. and TODARO, G.J. (1978). Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA 75: 4001-4005.
20. DEFIZE, L.H.K. (1988). Activation of the human epidermal growth factor receptor. Thesis, Utrecht University.
21. DEFIZE, L.H.K., BOONSTRA, J., MEISENHELDER, J., KRUIJER, W., TERTOOLEN, L.G.J., TILLY, B.C., HUNTER, T., VAN BERGEN EN HENEGOUWEN, P.M.P., MOOLENAAR, W.H. and DE LAAT, S.W. (1989). Signal transcuction by epidermal growth factor occurs through the subclass of high affinity receptors. J. Cell Biol. 109: 2495-2507.
22. DEFIZE, L.H.K., MOOLENAAR, W.H., VAN DER SAAG, P.T. and DE LAAT, S.W. (1986). Dissociation of cellular responses to epidermal growth factor using antireceptor monoclonal antibodies. EMBO J. 5: 1187-1192.
23. DEFIZE, L.H.K., MUMMERY, C.L., MOOLENAAR, W.H. and DE LAAT, S.W. (1987). Antireceptor antibodies in the study of EGF-receptor interaction. Cell Differ. 20: 87-102.
24. DEN HERTOG, J., DE GROOT, R.P., DE LAAT, S.W. and KRUIJER, W. (1992). EGF-induced jun B-expression in transfected P19 embryonal carcinoma cells expressing EGF-receptors is dependent on Jun D. Nucleic Adds Res. 20: 125-130.
25. DEN HERTOG, J., DE LAAT, S.W., SCHLESSINGER, J. and KRUIJER, W. (1991). Neuronal differentiation in response to epidermal growth factor of transfected murine P19 embryonal carcinoma cells expressing human epidermal growth factor receptors. Cell Growth Differ. 2: 155-164.
26. DOWNWARD, J., YARDEN, Y., MAYES, E., SCRACE, G., TOTTY, N., STOCKWELL, P., ULLRICH, A., SCHLESSINGER, J. and WATERFIELD, M.D. (1984). Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307: 521-527.
27. FANGER, B.O., AUSTIN, K.S., EARP, H.S. and CIDLOWSKI, J.A. (1986). Cross-linking of epidermal growth factor receptors in intact cells: detect on of initial stages of receptor clustering and determination of molecular weight of high-affinity receptors. Biochemistry 25: 6414-6420.
28. GADELLA, T.W.J. and JOVIN, T.M. (1995). Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation. J. Cell Biol. 129: 1543-1558.
29. GALE, N.W., KAPLAN, S., LOWENSTEIN, E.J., SCHLESSINGER. J. and BAR-SAGI, D. (1993). Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 363: 88-92.
30. GILL, G.N., KAWAMOTO, T., COCHET, C., LE, A., SATO, J.D., MASUI, H., MCLEOD, C. and MENDELSOHN, J. (1984). Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem. 259: 7755-7760.
31. GILL, G.N., SANTOS, J.B. and BERTICS, P.J. (1987). Regulatory features of the epidermal growth factor receptor. J. Cell Physiol. 5 (Suppl): 35-41.
32. GREENBERG, M.E. and ZIFF, E.B. (1984). Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311: 433-438.
33. HAIGLER, H., ASH, J.F. and COHEN, S. (1978). Visualization by f uorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A431. Proc. Natl. Acad. Sci, USA 75: 3317-3321.
34. HAMIL, O.P., MARTY, A., NEHER, E., SACKMANN, B. and SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391: 85-100.
35. HANDLER, J.A., DANILOWICZ, R.M. and ELING, T.E. (1990). Mitogenic signalling by epidermal growth factor (EGF), but not platelet derived growth factor, requires AA metabolism in BALB/c 3T3 cells. J. Biol. Chem. 265: 3669-3673.
36. HONEGGER, A.M., DULL, T.J., FELDER, S., VAN OBBERGHEN, E., BELLOT, F., SZAPARY, D., SCHMIDT, A., ULLRICH, A. and SCHLESSINGER, J. (1987). Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell 51: 199-209.
37. HUNTER, T. (1997). Oncoprotein networks. Cell 88: 333-346.
38. JALINK, K., VAN CORVEN, E.J., HENGEVELD, T., MORII, N., NARUMIYA, S. and MOOLENAAR, W.H. (1994). Inhibition of lysophosphatidate-and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J. Cell. Biol. 126: 801-810.
39. KASHLES, O., SZAPARY, D., BELLOT, F., ULLRICH, A., SCHLESSINGER, J. and SCHMIDT, A. (1988). Ligand-induced stimulation of EGF receptor mutants with altered transmembrane regions. Proc. Natl. Acad. Sci. USA 85: 9567-9571.
40. KIM, B.C. and KIM, J.H. (1997). Nuclear signalling by rac GTPase: essential role of phospholipase A2. Biochem. J. 326: 333-337.
41. KOLAND, J.G. and CERIONE, R.A. (1988). Growth factor control of epidermal growth factor receptor kinase activity via an intramolecular mechanism. J. Biol. Chem. 263: 2230-2237.
42. KRUIJER, W., COOPER, J.A., HUNTER, T. and VERMA, I.M. (1984). Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature 312: 711-716.
43. LEMMON, M.A. and SCHLESSINGER, J. (1994). Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci. 19: 459-463.
44. 2 is coupled to the hormonally regulated release of arachidonic acid. Proc. Natl. Acad. Sci. USA 89: 6147-6151.
45. 2 is phosphorylated and activated by MAP kinase. Cell 72: 269-278.
46. LOWENSTEIN, E.J., DALY, R.J., BATZER, A.G., LI, W., MARGOLIS, B., LAMMERS, R., ULLRICH, A., SKOLNIK, E.Y., BAR-SAGI, D. and SCHLESSINGER, J. (1992). The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70: 431-442.
47. MARSHALL, C.J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
48. MIETTINEN, P.J., BERGER, J.E., MENESES, J., PHUNG, Y., PEDERSEN, R.A., WERB, Z. and DERYNCK, R. (1995). Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376: 337-341.
49. MOOLENAAR, W.H., AERTS, R.J., TERTOOLEN, L.G.J. and DE LAAT, S.W. (1986). The epidermal growth factor induced calcium signal in A431 cells. J. Biol. Chem. 261: 279-285.
50. MOOLENAAR, W.H., BIERMAN, A.J., TILLY, B.C., VERLAAN, I., DEFIZE, L.H.K., HONEGGER, A.M., ULLRICH, A. and SCHLESSINGER, J. (1988). A point mutation at the ATP-binding site of the EGF-receptor abolishes signal transduction. EMBO J. 7: 707-710.
51. MOOLENAAR, W.H., TERTOOLEN, L.G.J. and DE LAAT, S.W. (1984). Growth factors immediately raise cytoplasmic free Ca2+ in human fibroblasts. J. Biol. Chem. 259: 8066-8069.
52. + exchange in the action of growth factors in human fibroblasts. Nature 304: 645-648.
53. MUMMERY, C.L., FEIJEN, A., VAN DER SAAG, P.T., VAN DEN BRINK, C.E. and DE LAAT, S.W. (1985). Clonal variants of differentiated P19 embryonal carcinoma cells exhibit epidermal growth factor receptor kinase activity. Dev. Biol. 109: 402-410.
54. OLIVIER, J.P., RAABE, T., HENKEMEYER, M., DICKSON, B., MBAMALU, G., MARGOLIS, B., SCHLESSINGER, J., HAFEN, E. and PAWSON, T. (1993). A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of Ras guanine nucleotide exchange, Sos. Cell 73: 179-191.
55. PAWSON, T. (1995). Protein modules and signalling networks. Nature 373: 573-580.
56. PAWSON, T. and SCOTT, J.D. (1997). Signaling through scaffold, anchoring, and adaptor proteins. Science 278: 2075-2080.
57. PEPPELENBOSCH, M.P., QIU, R.G., DE VRIES-SMITS, A.M., TERTOOLEN, L.G.J., DE LAAT, S.W., MCCORMICK, F., HALL, A., SYMONS, M.H. and BOS, J.L. (1995). Rac mediates growth factor-induced arachidonic acid release. Cell 81: 849-856.
58. PEPPELENBOSCH, M.P., TERTOOLEN, L.G.J. and DE LAAT, S.W. (1991). Epidermal growth factor-activated calcium and potassium channels. J. Biol. Chem. 266: 19938-19944.
59. 4 production. Cell 69: 295-303.
60. PEPPELENBOSCH, M.P., TERTOOLEN, L.G.J., HAGE, W.J. and DE LAAT, S.W. (1993). Epidermal growth factor-induced actin remodelling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell 74: 565-575.
61. PINTO DA SILVA, P. and KAN, F.W.K. (1984). Label-fracture: a method for high resolution labelling of cell surfaces. J. Cell Biol. 99: 1156-1161.
62. RIDLEY, A.J. and HALL, A. (1992). The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399.
63. RIDLEY, A.J. PATERSON, H.F., JOHNSTON, C.L., DIEKMANN, D. and HALL, A. (1992). The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70: 401-410.
64. RIJKEN, P.J., HAGE, W.J., VAN BERGEN EN HENEGOUWEN, P.M.P., VERKLEIJ, A.J. and BOONSTRA, J. (1991). Epidermal growth factor induces rapid reorganization of the actin microfilament system in human A431 cells. J. Cell Sci. 100: 491-499.
65. RINGERIKE, T., STANG, E., JOHANNESSEN, L.E., SANDNES, D., LEVY, F.O. and MADSHUS, I.H. (1998). High-affinity binding of epidermal growth factor (EGF) to EGF receptor is disrupted by overexpression of mutant dynamin (K44A). J. Biol. Chem. 273: 16639-16642.
66. + antiporter, a glycoprotein of 110 kD. Science 247: 723-726.
67. SAWYER, S.T. and COHEN, S. (1981). Enhancement of calcium uptake and phosphatidylinositol turnover by epidermal growth factor in A-431 cells. Biochemistry 27: 6280-6286.
68. SCHAEFFER, H.J., CATLING, A.D., EBLEN, S.T., COLLIER, L.S., KRAUSS, A. and WEBER, M.J. (1998). MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281: 1668-1671.
69. 2. Eur. J. Biochem. 231: 593-601.
70. SCHLESSINGER, J. (1988). Signal transduction by allosteric receptor oligomerization. Treds. Biochem. Sci. 13: 443-447.
71. SCHLESSINGER, J. (1990). Mutational analysis of the epidermal growth factor-receptor kinase. Biochem. Soc. Symp. 56: 13-19.
72. SCHLESSINGER, J. (1993). SH2/SH3 signaling proteins. Curr. Opin. Genet. Dev. 4: 25-30.
73. SCHLESSINGER, J. and GEIGER, B. (1981). Epidermal growth factor induces redistribution of actin and alpha-actinin in human epidermal carcinoma cells. Exp. Cell Res. 134: 273-279.
74. SCHREIBER, A.B., LIBERMAN, T.A., LAX, I., YARDEN, Y. and SCHLESSINGER, J. (1983). Biological role of epidermal growth factor-receptor clustering. Investigation with monoclonal anti-receptor antibodies. J. Biol. Chem. 258: 846-853.
75. SELLMAYER, A., UEDELHOVEN, W.M., WEBER, P.C. and BONVENTRE, J.V. (1991). Endogenous non-cyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesanglial cells. J. Biol. Chem. 266: 3800-3807.
76. SHOYAB, M., DELARCO, J.E. and TODARO, G.J. (1979). Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors. Nature 279: 387-391.
77. SIBILIA, M. and WAGNER, E.F. (1995). Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269: 234-238.
78. SIBILIA, M., STEINBACH, J.P., STINGL, L., AGUZZI, A. and WAGNER, E.F. (1998). A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J. 17: 719-731.
79. SONGYANG, Z. and CANTLEY, L.C. (1995). Recognition and specificity in protein tyrosine kinase-mediated signalling. Trends Biochem. Sci. 20: 470-475.
80. SPAARGAREN, M., DEFIZE, L.H.K., BOONSTRA, J. and DE LAAT, S.W. (1991). Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase. J. Biol. Chem. 266: 1733-1739.
81. SPAARGAREN, M., DEFIZE, L.H.K., DE LAAT, S.W. and BOONSTRA, J. (1990). Antibody-induced activation of the epidermal growth factor receptor tyrosine kinase requires the presence of detergent. Biochem. Biophys. Res. Commun 171: 882-889.
82. 2. Biochem. J. 287: 37-43.
83. THREADGILL, D.W., DLUGOSZ, A.A., HANSEN, L.A., TENNENBAUM, T., LICHTI, U., YEE, D., LAMANTIA, C., MOURTON, T., HERRUP, K., HARRIS, R.C., BARNARD, J.A., YUSPA, S.H., COFFEY, R.J. and MAGNUSON, T. (1995). Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234.
84. TILLY, B.C., VAN PARIDON, P.A, VERLAAN, I., DE LAAT, S.W. and MOOLENAAR, W.H. (1988). Epidermal growth factor-induced formation of inositol phosphates in human A431 cells. Biochem. J. 252: 857-863.
85. TREISMAN, R. (1985). Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences. Cell 42: 889-902.
86. TUPPER, J.T. (1978). Serum-stimulated changes in calcium transport and distribution in mouse 3T3 cells and their modification by dibutyryl cyclic AMP. J. Cell. Physiol. 95: 71-84.
87. USHIRO, H. and COHEN, S. (1980). Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J. Biol. Chem. 255: 8363-8365.
88. VAN BELZEN, N., SPAARGAREN, M., VERKLEIJ, A.J. and BOONSTRA, J. (1988). Interaction of the epidermal growth factor receptor with the cytoskeleton is related to receptor clustering. J. Cell. Physiol. 145: 365-375.
89. VAN BERGEN, E.N., HENEGOUWEN, P.M., DEFIZE, L.H., DE KROON, J., VAN DAMME, H., VERKLEIJ, A.J. and BOONSTRA, J. (1989). Ligand-induced association of epidermal growth factor receptor to the cytoskeleton of A431 cells. J. Cell. Biochem. 39: 455-465.
90. VAN DER GEER, P. and PAWSON, T. (1995). The PTB domain: a new protein module implicated in signal transduction. Trends Biochem. Sci. 20: 277-280.
91. VAN DER HEYDEN, M.A.G., NIEVERS, M., VERKLEIJ, A.J., BOONSTRA, J. and VAN BERGEN EN HENEGOUWEN, P.M.P. (1997). Identification of an intracellular domain of the EGF receptor required for high-affinity binding of EGF. FEBS Lett. 410: 265-268.
92. VAN ZOELEN, E.J. (1990). The use of biological assays for detection of polypeptide growth factors. Prog. Growth Factor Res. 2: 131-152.
93. VAN ZOELEN, E.J. (1991). Phenotypic transformation of normal rat kidney cells: a model for studying cellular alterations in oncogenesis. Crit. Rev. Oncog. 2: 311-333.
94. VAN ZOELEN, E.J., TWARDZIK, D.R., VAN OOSTWAARD, T.M., VAN DER SAAG, P.T., DE LAAT, S.W. and TODARO, G.J. (1984). Netroblastoma cells produce transforming growth factors during exponential growth in a defined hormone-free medium. Proc. Natl. Acad. Sci. USA 81: 4085-4089.
95. VAN ZOELEN, E.J., WARD-VAN OOSTWAARD, T.M., NIEUWLAND, R., VAN DER BURG, B., VAN DEN EIJNDEN-VAN RAAIJ, A.J., MUMMERY, C.L. and DE LAAT, S.W. (1989). Identification and characterization of polypeptide growth factors secreted by murine embryonal carcinoma cell 3. Dev. Biol. 133: 272-283.
96. WEBER, W., BERTICS, P.J. and GILL, G.N. (1984). Immuno-affinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation. J. Biol. Chem. 259: 14631-14636.
97. WHITMARSH, A.J. and DAVIS, R.J. (1998). Structural organization of MAP-kinase signalling modules by scaffold proteins in yeast and mammals. Trens Biochem. Sci. 23: 481-485.
98. WIEGANT, F.A., BLOK, F.J., DEFIZE, L.H., LINNEMANS, W.A , VERKLEY, A.J. and BOONSTRA, J. (1986). Epidermal growth factor receptors associated to cytoskeletal elements of epidermoid carcinoma (A431) cells J. Cell Biol. 103: 87-94.
99. YANG, S.H., WHITMARSH, A.J., DAVIS, R.J. and SHARROCKS, A.D. (1998). Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J. 17: 1740-1749.
100. YARDEN, Y. and SCHLESSINGER, J. (1987a). Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26: 1434-1442.
101. YARDEN, Y. and SCHLESSINGER, J. (1987b). Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26: 1443-1451.